Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn

Multiple functions have recently been identified for the neonatal Fc receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has been identified and characterized. This major histocompatibility complex class I-related receptor plays a role in the passive delivery of immunoglobulin (I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annual review of immunology 2000-01, Vol.18 (1), p.739-766
Hauptverfasser: Ghetie, Victor, Ward, E. Sally
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 766
container_issue 1
container_start_page 739
container_title Annual review of immunology
container_volume 18
creator Ghetie, Victor
Ward, E. Sally
description Multiple functions have recently been identified for the neonatal Fc receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has been identified and characterized. This major histocompatibility complex class I-related receptor plays a role in the passive delivery of immunoglobulin (Ig)Gs from mother to young and the regulation of serum IgG levels. In addition, FcRn expression in tissues such as liver, mammary gland, and adult intestine suggests that it may modulate IgG transport at these sites. These diverse functions are apparently brought about by the ability of FcRn to bind IgGs and transport them within and across cells. However, the molecular details as to how FcRn traffics within cells have yet to be fully understood, although in vitro systems have been developed for this purpose. The molecular nature of the FcRn-IgG interaction has been studied extensively and encompasses residues located at the CH2-CH3 domain interface of the Fc region of IgG. These Fc amino acids are highly conserved in rodents and man and interact with residues primarily located on the 2 domain of FcRn. Thus, it is now possible to engineer IgGs with altered affinities for FcRn, and this has relevance to the modulation of IgG serum half-life and maternofetal IgG transport for therapeutic applications.
doi_str_mv 10.1146/annurev.immunol.18.1.739
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_10837074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71162645</sourcerecordid><originalsourceid>FETCH-LOGICAL-a462t-a63c61a8e8a6e8d09d58142a24d9927d878259409abbe7a46bcfd2322fec9dee3</originalsourceid><addsrcrecordid>eNqNkE9LwzAchoMobk6_guTkrTV_2iY9eJDh3MAhDPUa0vZXzEj_2KTqvr0Z28Gbnn4JPO_7woMQpiSmNMludduOA3zGpmnGtrMxlTGNBc9P0JSmSRpxJuQpmhLBWURSySbowrktISTnXJyjCSWSCyKSKXpbj9ab3gLedBYcrrsB-3fAa70Nr6Vxviu7ptfeFMYav8Pz8LPwjedWO4dXEd6A1R6qcEvofQgtyk17ic5qbR1cHe8MvS4eXubL6On5cTW_f4p0kjEf6YyXGdUSpM5AViSvUkkTpllS5TkTlRSSpXlCcl0UIEKmKOuKccZqKPMKgM_QzaG3H7qPEZxXjXElWKtb6EanBKUZy5L0T5CKNMyIPSgPYDl0zg1Qq34wjR52ihK1l6-O8tVRvqJSURXkh-j1cWMsGqh-BQ-2A3B3APYV2oYSA1_u_wM_BT6b-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17540975</pqid></control><display><type>article</type><title>Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn</title><source>Annual Reviews Complete A-Z List</source><source>MEDLINE</source><creator>Ghetie, Victor ; Ward, E. Sally</creator><creatorcontrib>Ghetie, Victor ; Ward, E. Sally</creatorcontrib><description>Multiple functions have recently been identified for the neonatal Fc receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has been identified and characterized. This major histocompatibility complex class I-related receptor plays a role in the passive delivery of immunoglobulin (Ig)Gs from mother to young and the regulation of serum IgG levels. In addition, FcRn expression in tissues such as liver, mammary gland, and adult intestine suggests that it may modulate IgG transport at these sites. These diverse functions are apparently brought about by the ability of FcRn to bind IgGs and transport them within and across cells. However, the molecular details as to how FcRn traffics within cells have yet to be fully understood, although in vitro systems have been developed for this purpose. The molecular nature of the FcRn-IgG interaction has been studied extensively and encompasses residues located at the CH2-CH3 domain interface of the Fc region of IgG. These Fc amino acids are highly conserved in rodents and man and interact with residues primarily located on the 2 domain of FcRn. Thus, it is now possible to engineer IgGs with altered affinities for FcRn, and this has relevance to the modulation of IgG serum half-life and maternofetal IgG transport for therapeutic applications.</description><identifier>ISSN: 0732-0582</identifier><identifier>EISSN: 1545-3278</identifier><identifier>DOI: 10.1146/annurev.immunol.18.1.739</identifier><identifier>PMID: 10837074</identifier><language>eng</language><publisher>Palo Alto, CA 94303-0139: Annual Reviews</publisher><subject>AFc receptors ; Animals ; gammaglobulin ; Histocompatibility Antigens Class I - immunology ; Humans ; Immunoglobulin G - immunology ; maternofetal intestinal transfer of IgGs ; neonatal Fc receptor ; Receptors, Fc - immunology ; serum half-life ; transcytosis</subject><ispartof>Annual review of immunology, 2000-01, Vol.18 (1), p.739-766</ispartof><rights>Copyright © 2000 by Annual Reviews. All rights reserved</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a462t-a63c61a8e8a6e8d09d58142a24d9927d878259409abbe7a46bcfd2322fec9dee3</citedby><cites>FETCH-LOGICAL-a462t-a63c61a8e8a6e8d09d58142a24d9927d878259409abbe7a46bcfd2322fec9dee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev.immunol.18.1.739?crawler=true&amp;mimetype=application/pdf$$EPDF$$P50$$Gannualreviews$$H</linktopdf><linktohtml>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev.immunol.18.1.739$$EHTML$$P50$$Gannualreviews$$H</linktohtml><link.rule.ids>70,314,776,780,4168,27901,27902,77997,77998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10837074$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghetie, Victor</creatorcontrib><creatorcontrib>Ward, E. Sally</creatorcontrib><title>Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn</title><title>Annual review of immunology</title><addtitle>Annu Rev Immunol</addtitle><description>Multiple functions have recently been identified for the neonatal Fc receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has been identified and characterized. This major histocompatibility complex class I-related receptor plays a role in the passive delivery of immunoglobulin (Ig)Gs from mother to young and the regulation of serum IgG levels. In addition, FcRn expression in tissues such as liver, mammary gland, and adult intestine suggests that it may modulate IgG transport at these sites. These diverse functions are apparently brought about by the ability of FcRn to bind IgGs and transport them within and across cells. However, the molecular details as to how FcRn traffics within cells have yet to be fully understood, although in vitro systems have been developed for this purpose. The molecular nature of the FcRn-IgG interaction has been studied extensively and encompasses residues located at the CH2-CH3 domain interface of the Fc region of IgG. These Fc amino acids are highly conserved in rodents and man and interact with residues primarily located on the 2 domain of FcRn. Thus, it is now possible to engineer IgGs with altered affinities for FcRn, and this has relevance to the modulation of IgG serum half-life and maternofetal IgG transport for therapeutic applications.</description><subject>AFc receptors</subject><subject>Animals</subject><subject>gammaglobulin</subject><subject>Histocompatibility Antigens Class I - immunology</subject><subject>Humans</subject><subject>Immunoglobulin G - immunology</subject><subject>maternofetal intestinal transfer of IgGs</subject><subject>neonatal Fc receptor</subject><subject>Receptors, Fc - immunology</subject><subject>serum half-life</subject><subject>transcytosis</subject><issn>0732-0582</issn><issn>1545-3278</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE9LwzAchoMobk6_guTkrTV_2iY9eJDh3MAhDPUa0vZXzEj_2KTqvr0Z28Gbnn4JPO_7woMQpiSmNMludduOA3zGpmnGtrMxlTGNBc9P0JSmSRpxJuQpmhLBWURSySbowrktISTnXJyjCSWSCyKSKXpbj9ab3gLedBYcrrsB-3fAa70Nr6Vxviu7ptfeFMYav8Pz8LPwjedWO4dXEd6A1R6qcEvofQgtyk17ic5qbR1cHe8MvS4eXubL6On5cTW_f4p0kjEf6YyXGdUSpM5AViSvUkkTpllS5TkTlRSSpXlCcl0UIEKmKOuKccZqKPMKgM_QzaG3H7qPEZxXjXElWKtb6EanBKUZy5L0T5CKNMyIPSgPYDl0zg1Qq34wjR52ihK1l6-O8tVRvqJSURXkh-j1cWMsGqh-BQ-2A3B3APYV2oYSA1_u_wM_BT6b-A</recordid><startdate>20000101</startdate><enddate>20000101</enddate><creator>Ghetie, Victor</creator><creator>Ward, E. Sally</creator><general>Annual Reviews</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20000101</creationdate><title>Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn</title><author>Ghetie, Victor ; Ward, E. Sally</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a462t-a63c61a8e8a6e8d09d58142a24d9927d878259409abbe7a46bcfd2322fec9dee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>AFc receptors</topic><topic>Animals</topic><topic>gammaglobulin</topic><topic>Histocompatibility Antigens Class I - immunology</topic><topic>Humans</topic><topic>Immunoglobulin G - immunology</topic><topic>maternofetal intestinal transfer of IgGs</topic><topic>neonatal Fc receptor</topic><topic>Receptors, Fc - immunology</topic><topic>serum half-life</topic><topic>transcytosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghetie, Victor</creatorcontrib><creatorcontrib>Ward, E. Sally</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Annual review of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghetie, Victor</au><au>Ward, E. Sally</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn</atitle><jtitle>Annual review of immunology</jtitle><addtitle>Annu Rev Immunol</addtitle><date>2000-01-01</date><risdate>2000</risdate><volume>18</volume><issue>1</issue><spage>739</spage><epage>766</epage><pages>739-766</pages><issn>0732-0582</issn><eissn>1545-3278</eissn><abstract>Multiple functions have recently been identified for the neonatal Fc receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has been identified and characterized. This major histocompatibility complex class I-related receptor plays a role in the passive delivery of immunoglobulin (Ig)Gs from mother to young and the regulation of serum IgG levels. In addition, FcRn expression in tissues such as liver, mammary gland, and adult intestine suggests that it may modulate IgG transport at these sites. These diverse functions are apparently brought about by the ability of FcRn to bind IgGs and transport them within and across cells. However, the molecular details as to how FcRn traffics within cells have yet to be fully understood, although in vitro systems have been developed for this purpose. The molecular nature of the FcRn-IgG interaction has been studied extensively and encompasses residues located at the CH2-CH3 domain interface of the Fc region of IgG. These Fc amino acids are highly conserved in rodents and man and interact with residues primarily located on the 2 domain of FcRn. Thus, it is now possible to engineer IgGs with altered affinities for FcRn, and this has relevance to the modulation of IgG serum half-life and maternofetal IgG transport for therapeutic applications.</abstract><cop>Palo Alto, CA 94303-0139</cop><cop>4139 El Camino Way, P.O. Box 10139</cop><cop>USA</cop><pub>Annual Reviews</pub><pmid>10837074</pmid><doi>10.1146/annurev.immunol.18.1.739</doi><tpages>28</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0732-0582
ispartof Annual review of immunology, 2000-01, Vol.18 (1), p.739-766
issn 0732-0582
1545-3278
language eng
recordid cdi_pubmed_primary_10837074
source Annual Reviews Complete A-Z List; MEDLINE
subjects AFc receptors
Animals
gammaglobulin
Histocompatibility Antigens Class I - immunology
Humans
Immunoglobulin G - immunology
maternofetal intestinal transfer of IgGs
neonatal Fc receptor
Receptors, Fc - immunology
serum half-life
transcytosis
title Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T06%3A20%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20Roles%20for%20the%20Major%20Histocompatibility%20Complex%20Class%20I-%20Related%20Receptor%20FcRn&rft.jtitle=Annual%20review%20of%20immunology&rft.au=Ghetie,%20Victor&rft.date=2000-01-01&rft.volume=18&rft.issue=1&rft.spage=739&rft.epage=766&rft.pages=739-766&rft.issn=0732-0582&rft.eissn=1545-3278&rft_id=info:doi/10.1146/annurev.immunol.18.1.739&rft_dat=%3Cproquest_pubme%3E71162645%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17540975&rft_id=info:pmid/10837074&rfr_iscdi=true